FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Insulin Detemir Injection
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism; Other

Expand all

Novo Nordisk (New 11/08/2023)

Company Contact Information:
609-987-5800

Presentation	Posting Date	Related Information
Levemir, Injection, 100 [iU]/1 mL (NDC 0169-6432-10)	11/08/2023	Limited supply of Levemir® FlexPen® through the end of 2024. Full brand discontinuation will occur on December 31, 2024.
Levemir, Injection, 100 [iU]/1 mL (NDC 0169-3687-12)	11/08/2023	Levemir® vials will be available until the end of 2024. Full brand discontinuation will occur on December 31, 2024.